| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.74M | - | |
| Other | 21.6K | $1.35M | - | |
| Other | 15.4K | $964.0K | -5,538 | |
| Dir | 8.0K | $499.6K | - | |
| Dir | 8.0K | $499.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | Chess Robert84 | Director | Sale+OE | 5,000 | $14.10 | $70,500.00 | -1.9% | |
| Jun 1, 2016 | Chess Robert84 | Director | Sale+OE | 5,000 | $15.50 | $77,500.00 | -1.9% | |
| May 17, 2016 | Nicholson John | SVP &Chief Financial Officer | Sale+OE | 856 | $13.58 | $11,624.48 | -1.1% | |
| May 17, 2016 | Robin Howard W58 | President &CEO | Sale+OE | 2,170 | $13.58 | $29,468.60 | -11.4% | |
| May 17, 2016 | Doberstein Stephen K | SVP &Chief Scientific Officer | Sale+OE | 339 | $13.58 | $4,603.62 | -24.9% | |
| May 17, 2016 | Gergel Ivan P. | SVP &Chief Medical Officer | Sale+OE | 432 | $13.58 | $5,866.56 | -22.2% | |
| May 17, 2016 | Hora Maninder | SVP Pharma Dev &Mfg Ops | Sale+OE | 835 | $13.58 | $11,339.30 | -10.5% | |
| May 17, 2016 | Labrucherie Gil M84 | SVP &General Counsel | Sale+OE | 836 | $13.58 | $11,352.88 | -9.5% | |
| May 17, 2016 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sale+OE | 724 | $13.58 | $9,831.92 | -10.3% | |
| Apr 25, 2016 | Lingnau Lutz | Director | Sale+OE | 15,000 | $16.27 | $244,050.00 | -47.7% |